fda rules on compounded semaglutide is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified 🚨 FDA Moves to Permanently

Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, et al

nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia Definitions the present invention relates generally to the treatment of autism spectrum disorder (ASD)

Anyone who is 18 years or older and located in Canada

Dexcom has been chosen as the first participant in FDAs Technology-Enabled Meaningful Patient Outcomes (TEMPO) for digital health devices pilot that the agency has developed with the Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS)

Dividing your daily dose into two or three smaller amounts taken with meals containing healthy fats may also improve tolerability

Effect of electrical stimulation of the LES on LES pressure in a canine model